Sutro Biopharma (STRO) Shares Outstanding (2016 - 2026)

Sutro Biopharma has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $8.6 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 4.02% year-over-year to $8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 million (up 4.02% YoY) and the FY2025 annual result came in at $8.6 million, up 4.02% from the prior year.
• Shares Outstanding (Entity) grew to $8.6 million in Q4 2025 per STRO's latest filing, from $8.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $8.6 million in Q4 2025 and troughed at $4.6 million in Q1 2021.
• A 5-year average of $6.4 million and a median of $6.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) soared 98.49% in 2021, then gained 1.79% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $4.6 million in 2021, then gained by 24.12% to $5.7 million in 2022, then gained by 6.1% to $6.1 million in 2023, then soared by 35.27% to $8.3 million in 2024, then increased by 4.02% to $8.6 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $8.6 million, $8.5 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.